IMMUNITY STATUS IN PATIENTS WITH BASAL CELL SKIN CARCINOMA


Cite item

Full Text

Abstract

Aim. To study the immune status in patients with basal cell skin carcinoma in the postoperative period. Materials and methods. The immune status changes were performed in 39 patients with basal cell skin carcinoma (BCSC). Patients’ age was 65±3 years. To asses the immune status, content of different lymphocyte subpopulations in blood, immune humoral component indices, cytokine content, phagocytosis parameters were determined. Results. Patients with basal cell carcinoma were established to have in cell component of the immune system decreased percent and absolute number of lymphocytes carrying CD16+, CD3+, CD4+ and CD8+ mediators and lowered CD4+/CD8+ ratio index. At the same time, increase in lymphocytes carrying CD20+ receptors was registered. After surgical treatment, restoration of lymphocytes carrying CD20+ receptors alone was noted; the rest indices were not changed and remained decreased. Before surgical treatment, in the humoral component of the immune system, there was registered a decrease in IgG number, as well as reduction in the total number of compliment, its C3-and C4-fractions, TNF-α, IL1-b, IL-6, IF-γ, phagocytic index, phagocytic number, BT-sp., BT-st., with rise in CIC. On the postoperative day 7, a partial restoration of the humoral component indices of the immune status system was detected: CIC and NBT-sp. which became to correspond to the data of the comparison group consisting of relatively healthy persons were also restored. On the postoperative day 10, NBT-st. index was restored, besides, there was a partial restoration of such index as IgG. However, this index remained decreased compared to the data of the comparison group consisting of relatively healthy persons.

References

  1. Виксман М. Е., Маянский А. Н. Способ оценки функциональной активности нейтрофилов человека по реакции восстановления нитросинего тетразолия: методические рекомендации. Казань 1979; 42.
  2. Караулов А. В. Клиническая иммунология. М.: Медицина 2008; 40.
  3. Медведев А. Н., Чаленко В. В. Способы исследования поглотительной фазы фагоцитоза. Лаб. дело 1991; 2: 19-20.
  4. Петрунин Д. Д. Новые подходы к иммунотерапии базально-клеточного рака кожи: автореф. дис. … канд. мед. наук. М. 2011.
  5. Сергеев Ю. В., Борисова С. В., Шубина С. И. Современные подходы к профилактике рака кожи. Кремлевская медицина 2000; 1: 48-51.
  6. Тоталян А. А., Балдуева И. А., Бубнова Л. Н. Стандартизация методов иммунофенотипирования клеток крови и костного мозга человека. Мед. иммунология 1999; 1 (5): 21-43.
  7. Чиссов В. И., Старинский В. Д., Ковалев Б. Н. Стратегия и тактика онкологической службы России на современном этапе. Российский онкологический журнал 2006; 3: 4-7.
  8. Щербаков В. И. Применение НСТ-теста для оценки чувствительности нейтрофилов к стимуляторам. Лаб. дело 1989; 1: 30-33.
  9. Mancini J., Carhjonara A. O., Heremans Heremans Y. Immunochemical quantitation of antigens by single radial immunodiffusion. Inf. J. Immunochemistry 1965; 2: 235-254.
  10. Chinem V. P., Miot H. A. Epidemiology of basal cell carcinoma. An. Bras. Dermatol. 2011; 86: 292-305.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014 Maslyakov V.V., Dralina O.I., Fedotova E.V., Zakharov G.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 70264 от 13.07.2017 г
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 75489 от 05.04.2019 г
.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies